Competing risks in survival data analysis.
Where this comes from
- Record sourced from PubMed, PMID 30314718.
- Also identified by DOI 10.1016/j.radonc.2018.09.007.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Clinical trials and retrospective studies in the field of radiation oncology often consider time-to-event data as their primary endpoint. Such studies are susceptible to competing risks, i.e. competing events may preclude the occurrence of the event of interest or modify the chance that the primary endpoint occurs. Competing risks are frequently neglected and the event of interest is analysed with standard statistical methods. Here, we would like to create awareness of the problem and demonstrate different methods for survival data analysis in the presence of competing risks.
Medical subject headings
- Data Analysis
- Head and Neck Neoplasms
- Squamous Cell Carcinoma of Head and Neck
- Survival Analysis